Literature DB >> 2048825

Neutrophil retention in the lungs of patients with chronic obstructive pulmonary disease.

C Selby1, E Drost, S Lannan, P K Wraith, W MacNee.   

Abstract

In order to study neutrophil traffic in the lungs of humans, we harvested autologous neutrophils and radiolabeled them with indium-111 prior to reinjection. The passage of these [111In]neutrophils through the pulmonary vasculature was compared with that of [99mTc]erythrocytes in normal elderly subjects and in patients with chronic obstructive pulmonary disease (COPD). Neutrophil sequestration within the lungs of seven normal subjects, 10 min after reinjection, correlated with local erythrocyte transit times in the lungs (tau = 0.72, p less than 0.001). This relationship was lost in patients with COPD. In seven patients studied during an acute exacerbation of COPD, neutrophil retention was higher during the first passage through the lungs (mean, 22.0 SD 14.1%) compared with 14 patients studied when their condition was stable (16.3 SD 3.4%, p less than 0.001), or to the normal elderly subjects (13.7 SD 7.0%, p less than 0.001). In addition, the subsequent rate of neutrophil washout from the lungs was slower in patients with acute COPD (1.93 SD 0.66 x 10(-3)s1) than in those with stable disease (3.08 SD 1.8 x 10(-3)s-1, p less than 0.02). Neutrophil retention in the lungs correlated inversely with the extent of emphysema, assessed quantitatively by CT scanning (tau = 0.68, p less than 0.05). Thus, patients presenting with acute exacerbations of COPD have an increased neutrophil burden in the pulmonary vasculature with the potential for increased lung proteolysis.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2048825     DOI: 10.1164/ajrccm/143.6.1359

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  16 in total

1.  Cellular mechanisms of acute lung injury: implications for future treatment in the adult respiratory distress syndrome.

Authors:  S C Donnelly; C Haslett
Journal:  Thorax       Date:  1992-04       Impact factor: 9.139

Review 2.  COPD exacerbations . 2: aetiology.

Authors:  E Sapey; R A Stockley
Journal:  Thorax       Date:  2006-03       Impact factor: 9.139

3.  Oxidant/antioxidant imbalance in smokers and chronic obstructive pulmonary disease.

Authors:  I Rahman; W MacNee
Journal:  Thorax       Date:  1996-04       Impact factor: 9.139

4.  Polymorphonuclear neutrophils move into the fast lane in chronic obstructive pulmonary disease.

Authors:  Takahiro Nakajima; Caroline A Owen
Journal:  Am J Respir Crit Care Med       Date:  2011-05-01       Impact factor: 21.405

5.  Oxidative stress and airway inflammation in severe exacerbations of COPD.

Authors:  E M Drost; K M Skwarski; J Sauleda; N Soler; J Roca; A Agusti; W MacNee
Journal:  Thorax       Date:  2005-04       Impact factor: 9.139

Review 6.  New perspectives on basic mechanisms in lung disease. 2. Neutrophil traffic in the lungs: role of haemodynamics, cell adhesion, and deformability.

Authors:  W MacNee; C Selby
Journal:  Thorax       Date:  1993-01       Impact factor: 9.139

7.  Is there any relationship between plasma antioxidant capacity and lung function in smokers and in patients with chronic obstructive pulmonary disease?

Authors:  I Rahman; E Swarska; M Henry; J Stolk; W MacNee
Journal:  Thorax       Date:  2000-03       Impact factor: 9.139

8.  [18F]fluorodeoxyglucose positron emission tomography for lung antiinflammatory response evaluation.

Authors:  Delphine L Chen; Timothy J Bedient; James Kozlowski; Daniel B Rosenbluth; Warren Isakow; Thomas W Ferkol; Betsy Thomas; Mark A Mintun; Daniel P Schuster; Michael J Walter
Journal:  Am J Respir Crit Care Med       Date:  2009-07-02       Impact factor: 21.405

9.  Neutrophil sequestration in rat lungs.

Authors:  G M Brown; D M Brown; K Donaldson; E Drost; W MacNee
Journal:  Thorax       Date:  1995-06       Impact factor: 9.139

Review 10.  Targeted treatment in COPD: a multi-system approach for a multi-system disease.

Authors:  David Anderson; William Macnee
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2009-09-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.